Sort
78,016 grants matching “breast cancer”
Meiotic Chromosome Synapsis and Recombination in Yeast
$851,576Nancy E. Kleckner · Harvard University · R01 · FY2016 · GM
Advancing Systems Approaches to Personal and Population Breast Cancer Screening
$851,562Anna N. A. Tosteson · Dartmouth College · U54 · FY2012 · CA
Imaging Markers of Subclinical Cardiotoxicity in Breast Cancer
$851,351Reza Nezafat · Beth Israel Deaconess Medical Center · R01 · FY2017 · HL
Pharmacogenomics of Microtubule Targeting Agents
$851,184Deanna L Kroetz · University Of California, San Francisco · R01 · FY2015 · CA
Combined Digital X-Ray, Optical, and Ultrasound Breast Imaging
$850,772Paul L Carson · University Of Michigan At Ann Arbor · R01 · FY2009 · CA
Identifying driver mutations and tumor dependencies by comparative oncogenomics.
$850,689Scott W Lowe · Cold Spring Harbor Laboratory · U01 · FY2013 · CA
VANGUARD CENTER FOR WOMENS HEALTH INITIATIVE
$850,528University Of Pittsburgh At Pittsburgh · N01 · FY2000 · WH
ULTRASOUND-GUIDED TARGETED STING ACTIVATION FOR BREAST CANCER IMMUNOTHERAPY
$850,500The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2021 · Defense Health Agency
Basic Research Support for the CCR
$850,265Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
SINGAPORE COHORT STUDY OF DIET AND CANCER
$850,203University Of Southern California · R01 · FY2001 · CA
Process Development and Preclinical Advancement of a Novel Nanoparticle Formulation for Immune Activation
$850,188Richard Johnson · Saros Therapeutics Inc · R44 · FY2024 · CA
Liver Cancer Disparities in Alaska Native and American Indian People
$850,177George Ioannou · University Of Washington · P20 · FY2022 · CA
Cancer Risk Reduction and Diet: A Cohort Study of Women
$850,173Wei Zheng · Vanderbilt University · R01 · FY2006 · CA
Endogenous hormones and postmenopausal breast cancer: Etiologic insights and improving risk prediction
$850,128Susan E. Hankinson · University Of Massachusetts Amherst · R01 · FY2018 · CA
Sentinel Node Versus Axillary Dissection in Breast Cancer
$850,024David N Krag · University Of Vermont & St Agric College · R01 · FY2007 · CA
The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up
$850,000Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2021 · AT
Mouse Models of Human Breast Cancer
$850,000Baylor College Of Medicine · U01 · FY2004 · CA
Mouse Models for Human Cancer
$850,000Brigham And Women'S Hospital · U01 · FY2004 · CA
The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up
$850,000Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2022 · AT
The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up
$850,000Joann Elisabeth Manson · Brigham And Women'S Hospital · R01 · FY2023 · AT
Making hypomorphic tumor supressors in vivo using RNAi
$849,999Cold Spring Harbor Laboratory · U01 · FY2004 · CA
Cancer Proteome Center at Washington Univ, Univ of North Carolina
$849,998R Reid Townsend · Washington University · U24 · FY2016 · CA
An in vivo metastasis sensor
$849,562Lonnie D Shea · Northwestern University · R01 · FY2012 · CA
Breast CT scanner for earlier cancer detection
$849,549University Of California Davis · R01 · FY2003 · EB
Meiotic Chromosome Synapsis and Recombination in Yeast
$849,447Nancy E. Kleckner · Harvard University · R01 · FY2017 · GM